A eutectic mixture refers to a combination of two or more substances that, when mixed in a specific ratio, form a mixture with a lower melting point than any of the individual components alone. As a cardiac anesthesiologist and intensivist, I occasionally use a eutectic mixture of local anesthetics (EMLA) cream, which contains 2.5% lidocaine and 2.5% prilocaine. This eutectic formulation creates a liquid phase at room temperature, enhancing dermal absorption and allowing for adequate topical anesthesia without the need for local anesthesia injection before vascular access.
For adults, dosing is typically 2.5 g over 20–25 cm² for 1 hour or 2 g per 10 cm² for up to 2 hours in more involved cases. Pediatric dosing is age- and weight-based, with neonates requiring lower doses and shorter application times due to increased systemic absorption and immature metabolism.
The onset of dermal analgesia occurs ~1 hour after application, with a maximal effect at 2–3 hours and a post-removal duration of 1–2 hours. Compared to alternatives like ethyl chloride spray or subcutaneous lidocaine, EMLA is often preferred by patients for its noninvasive nature and comfort. Its analgesic efficacy is comparable to subcutaneous lidocaine, although less effective than intradermal infiltration.
Adverse effects are typically mild (transient blanching, erythema, localized edema), but clinicians should be aware of the rare risk of methemoglobinemia, especially in infants and those with G6PD deficiency. That said, studies have shown no clinically significant elevations in methemoglobin at recommended doses.
Leave a Reply